DAWN — Day One Biopharmaceuticals Inc · rev $131.2M

Day One Biopharmaceuticals Inc (DAWN) is a biotechnology company listed on US.

Latest reported DAWN revenue for 2024-12-31 was $131.2M. Net income was -$95.5M. DAWN currently screens at market cap $656.8M.

Use this DAWN page for company research — sector, financials, and the latest filing takeaway — not a live tape. The session quote (last, range, volume) lives on the DAWN quote page. Cached 10-K, 10-Q, 8-K, and Form 4 exhibits are on the DAWN SEC filings page. Lician reads the product cache first so this HTML stays unique to Day One Biopharmaceuticals Inc even when a live quote feed is slow.

Day One Biopharmaceuticals Inc latest statements (FY2024)

Latest cached year on this hub. Full DAWN income, balance, and cash tables.

  • Revenue$131.2M
  • Net Income-$95.5M
  • Total Assets$582.8M
  • Total Debt$0
  • Free Cash Flow$0

DAWN recent filings